HDC Health Intelligence Desk | Continuously Updated
Structured evaluations of dietary supplements, wellness products, and health-adjacent consumer offerings. Each brief applies a consistent analytical framework: ingredient evidence scoring, dosage adequacy assessment, claim verification against primary literature, formulation logic evaluation, and comparative market positioning.
Evaluation Framework
Every analysis published under the Health Intelligence designation follows the same structured methodology:
Ingredient Evidence Scoring: Each active compound is evaluated against its published research base. Scoring differentiates between robust clinical trial evidence, preliminary human studies, animal-model-only data, and traditional use without controlled research. Aggregate ingredient evidence determines the formulation's overall scientific grounding.
Dosage Adequacy Assessment: Label doses are compared against clinically studied ranges for each ingredient. A product can contain a well-researched compound at a therapeutically irrelevant dose — this distinction is captured systematically.
Claim Verification: Marketing language is compared directly against the evidence the manufacturer cites or implies. Unsupported claims, misleading study citations, and cherry-picked data points are identified and documented.
Formulation Logic: The ingredient combination is assessed for mechanistic coherence. Synergistic pairings, absorption considerations, and potential antagonistic interactions are noted.
Comparative Market Position: Pricing is contextualized against category alternatives delivering similar or identical active ingredients at comparable doses.
Published Analyses
Vision & Eye Health
SightCare — Structured Intelligence Brief
A multi-ingredient vision supplement evaluated across the HDC framework. Ingredient evidence scoring for lutein, zeaxanthin, bilberry, N-acetyl cysteine, and supporting compounds. Dosage adequacy assessment against AREDS2 trial benchmarks. Claim verification for marketed visual acuity and neuroprotective benefits.
Metabolic & Weight Management
Analysis of supplements targeting metabolic rate, appetite regulation, blood sugar balance, and body composition — evaluated through the lens of clinical evidence rather than marketing narrative.
Cardiovascular & Glycemic Wellness
Evaluations of formulations targeting glucose metabolism, lipid balance, and circulatory health. Particular attention to berberine-containing products given the compound's substantial clinical research base and the wide variation in product quality across the market.
Transdermal & Novel Delivery Systems
Assessment of products utilizing non-traditional delivery mechanisms (patches, sublingual formats, liquid preparations). The critical analytical question for these products is whether the delivery mechanism achieves meaningful bioavailability for the active compounds — a claim that requires specific pharmacokinetic evidence rather than theoretical extrapolation.
Analytical Standards
The HDC Health Intelligence Desk does not accept manufacturer funding, editorial review requests, or pre-publication access agreements. Analyses are produced independently using publicly available information, published research, and structured evaluation criteria.
When an analysis cannot be completed due to insufficient publicly available data (undisclosed proprietary blends, absent third-party testing, unverifiable manufacturer claims), that limitation is stated explicitly rather than filled with assumption.
Financial relationships with product companies exist through affiliate arrangements. These are disclosed in the attribution block at the conclusion of each analysis. Affiliate status does not influence scoring, conclusions, or comparative assessments.
This index is updated as new analyses are published.